Carcidiag Biotechnologies
About:
Carcidiag Biotechnologies is develops a diagnostic, fast, sensitive, specific and innovative tool for the detection of precancerous cells.
Website: https://carcidiag.com/
Description:
Carcidiag Biotechnologies develops a diagnostic, fast, sensitive, specific and innovative tool for the detection of precancerous cells for the prevention of carcinogenesis affecting the ENT sphere (tongue, pharynx, oral mucosa), the colorectal area and the lungs as well as the gynecological cancers.
Total Funding Amount:
1M EUR
Headquarters Location:
Guéret, Limousin, France
Founded Date:
2017-01-01
Founders:
Christian Laurance, Vincent Carre
Number of Employees:
1-10
Last Funding Date:
2017-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai